Abstract LB-401: A proteomics-based biomarker discovery platform for predicting clinical response to immune checkpoint inhibitor therapy in non-small cell lung cancer

2020 ◽  
Author(s):  
Michal Harel ◽  
Irena Khononov ◽  
Eran Issler ◽  
Coren Lahav ◽  
Ella Fremder ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Response ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitor ◽  
Biomarker Discovery ◽  
Checkpoint Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Checkpoint Inhibitor Therapy

scholarly journals Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer

2019 ◽  
Vol 39 (2) ◽  
pp. 815-825 ◽  
Author(s):  
MASAHIRO KATSURADA ◽  
TATSUYA NAGANO ◽  
MOTOKO TACHIHARA ◽  
TATSUNORI KIRIU ◽  
KOICHI FURUKAWA ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prognostic Factor ◽  
Small Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Tumor Size ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Checkpoint Inhibitor Therapy
Sign in / Sign up

Export Citation Format

Share Document